Redding, California - May 28, 2024
Antimicrobial Susceptibility Testing Market Expected to Reach $7.21 Billion by 2031
Antimicrobial Susceptibility Testing Market Size, Share, Forecast, & Trends Analysis by Product (Susceptibility Disks, Plates, MIC Strip) Test Type (Antibacterial, Antifungal) Method (Diffusion, Automated) Application End User - Global Forecast to 2031
Meticulous Research®—a leading global market research company, published a research report titled “Antimicrobial Susceptibility Testing Market Size, Share, Forecast, & Trends Analysis by Product (Susceptibility Disks, Plates, MIC Strip) Test Type (Antibacterial, Antifungal) Method (Diffusion, Automated) Application End User—Global Forecast to 2031.”
According to this latest publication from Meticulous Research®, the antimicrobial susceptibility testing market is expected to reach $7.21 billion by 2031, at a CAGR of 6.7% during the forecast period. The growth of this market is primarily driven by the growing risk of infectious diseases, rising incidences of infections due to antimicrobial-resistant pathogens, and growing concerns related to antimicrobial resistance globally. Moreover, supportive initiatives and funding for research in the area of AMR also support market growth. Furthermore, active R&D to develop rapid antimicrobial susceptibility testing and growth prospects in emerging markets are offering market opportunities.
Key Players
The key players profiled in the antimicrobial susceptibility testing market report are Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux S.A. (France), Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.), HiMedia Laboratories Pvt. Ltd. (India), MERLIN Diagnostika GmbH (Germany), Accelerate Diagnostics, Inc. (U.S.), Alifax S.r.l. (Italy), Creative Diagnostics (U.S.), Synbiosis (U.K.), and Zhuhai DL Biotech Co., Ltd (China).
The global antimicrobial susceptibility testing market is segmented by Product (Manual AST Products {Susceptibility Disks, Susceptibility Plates, and MIC Strips}, Consumables, and Automated AST Products), Method (Disk Diffusion, Automated AST, Dilution, and Other Methods), Test Types (Antibacterial Tests, Anti-parasitic Tests, Antifungal Tests, and Other Test Types), Application (Clinical Diagnostics, Drug Discovery, and Development, Other Applications), End User (Diagnostic Laboratories & Hospitals, Pharmaceutical and Biotechnology Companies, Research and Academic Institutes), Geography. The study also evaluates industry competitors and analyzes their market share at a global and regional level.
Among all the products covered in the report, in 2024, the manual antimicrobial susceptibility testing products segment is expected to account for the largest share of the antimicrobial susceptibility testing market. The large market share of this segment is driven by the low cost of manual AST products and simple handling procedures. The availability of a diverse range of consumables for manual testing and easy interpretation of tests are supporting market growth.
Among all the methods covered in the report, in 2024, the disk diffusion segment is expected to account for the largest share of the antimicrobial susceptibility testing market. The low cost associated with performing AST testing through the disk diffusion method and developments in the disk diffusion method with the use of automated technology is primarily supporting the segment’s large share. The disk diffusion method (also called the Kirby-Bauer method) is among the most flexible susceptibility testing methods used in clinical settings. This method is simple and practical and offers flexibility for the compounds being tested cost-effectively. It offers qualitative and interpretative results. Disk tests can be performed with Mueller-Hinton agar, which is available from multiple manufacturers and can be used with little or no requirement for additional instrumentation (e.g., calipers, a ruler, and an incubator). This makes it the least costly of all susceptibility methods.
Among all the test types studied in the report, in 2024, the antibacterial tests segment is expected to account for the largest share of the antimicrobial susceptibility testing market. The large market share of this segment is attributed to the higher use of antibacterial tests in clinical diagnosis, the growing incidence of bacterial infections, the emergence of antibiotic-resistant bacteria, cost-effectiveness, simple and fast interpretation, and ease of use and availability.
Among all the applications studied in the report, in 2024, the clinical diagnostics segment is expected to account for the largest share of the antimicrobial susceptibility testing market. The large market share of this segment is attributed to the rising burden of antimicrobial resistance and growing awareness about the use of antimicrobial susceptibility testing methods.
Among all the end users studied in the report, in 2024, the diagnostic laboratories and hospitals segment is expected to account for the largest share of the antimicrobial susceptibility testing market. The large market share of this segment is attributed to the availability of well-equipped facilities and trained/skilled technicians, the rise in hospital-acquired infections, and initiatives taken by key players to offer AST products through diagnostic laboratories & hospitals.
Geographic Review
This research report analyzes major geographies and provides comprehensive analysis for North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), Latin America, and the Middle East & Africa. North America is expected to account for the largest share of the antimicrobial susceptibility testing market in 2024, followed by Europe and Asia-Pacific. Factors driving the North American market include the adoption of technologically advanced susceptibility testing methods and continuous research for new drugs using ASTs, along with awareness about treatment options. Favorable government initiatives also support the growth of the North America market. For instance, in October 2020, the National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB), 2020–2025, was designed for coordinated, strategic actions to improve the health and well-being of all Americans by changing the course of antibiotic resistance.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5062
Key questions answered in the report-
- Which are the high growth market segments in terms of product, method, application, end user, and regions/countries?
- What was the historical market for antimicrobial susceptibility testing across the globe?
- What are the market forecasts and estimates for the period 2021-2028?
- What are the major drivers, restraints, challenges, and opportunities in the antimicrobial susceptibility testing market?
- Who are the major players in the antimicrobial susceptibility testing market?
- How is the competitive landscape and who are the market leaders in the antimicrobial susceptibility testing market?
- What are the recent developments in the antimicrobial susceptibility testing market?
- What are the different strategies adopted by the major players in the antimicrobial susceptibility testing market?
- What are the geographical trends and high growth regions/ countries?
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
